Compare Kroger Co (KR) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kroger Co vs Revvity Inc — how do they compare? Kroger Co trades at $56.14 (market cap $34.46B), while Revvity Inc trades at $116 (market cap $12.91B). The key difference: Kroger Co is far larger — about 2.7× Revvity Inc's market cap, and Kroger Co pays the higher dividend (2.56%). Which is the better fit depends on your goals.
| KR | RVTY | |
|---|---|---|
Market Cap | $34.46B | $12.91B |
Sector | Consumer Staples | Technology |
52-Week High | $75.60 | $117.75 |
52-Week Low | $55.53 | $82.26 |
Enterprise Value | $54.56B | $15.23B |
Dividend Yield | 2.56% | 0.24% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Kroger (KR) trades at $56.48, down 0.44% on the day, with a bearish technical signal driven by moving averages. The company reported mixed Q1 2026 earnings, missing EPS estimates by $0.01, but maintains a strong cash flow position with $2.08B net cash flow in 2025. Recent corporate actions include dividend payments, and news highlights e-commerce leadership changes and product recalls.
The outlook is balanced; analyst consensus is a Buy with a $68.25 price target, implying 21% upside, supported by stable revenue and margin expansion. Risks include competitive pressures, debt increase, and operational challenges from recent recalls. The stock offers value with a low P/S ratio but faces near-term technical headwinds.
RVTY trades at $115.18, down 0.72% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported strong Q2 2026 earnings of $1.41 per share, beating estimates, and raised its full-year outlook, driven by diagnostics strength and AI-enabled drug discovery. Revenue for 2025 was $2.86 billion with a net income margin of 8.16%, though valuation ratios like P/E of 55.64 appear elevated. Recent news includes product launches like the SuperFlex prenatal system and presentations at investor conferences.
The outlook is positive with analyst consensus favoring a buy rating and a $120.50 price target, suggesting upside. Key opportunities include robust diagnostics demand and innovation pipelines, while risks involve high valuation multiples and competitive pressures in the healthcare sector. Cash flow improved in 2026 to a net positive $31 million, supporting growth initiatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kroger Co
Kroger is the leading American grocer, with 2,726 supermarkets operating under several banners throughout the country as of the end of fiscal 2021. Around 83% of stores have pharmacies, while nearly 60% also sell fuel. The company also operates roughly 120 fine jewelry stores. Kroger features a leading private-label offering and manufactures around 30% of its own-brand units (and more than 40% of its grocery own-label assortment) itself, in 33 food production plants nationwide. Kroger is a top-two grocer in most of its major markets (as of early 2021, according to company data). Virtually all of Kroger's sales come from the United States.
Read more on KR →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
